These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients. Herzberg GZ, Rossi AF, Courtney M, Gelb BD. J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760 [Abstract] [Full Text] [Related]
13. Trends in invasive disease due to Candida species following heart and lung transplantation. Schaenman JM, Rosso F, Austin JM, Baron EJ, Gamberg P, Miller J, Oyer PE, Robbins RC, Montoya JG. Transpl Infect Dis; 2009 Apr; 11(2):112-21. PubMed ID: 19254327 [Abstract] [Full Text] [Related]
14. [Lung transplantation and the development of diabetes mellitus in adult patients with cystic fibrosis]. Navas de Solís MS, Merino Torres JF, Mascarell Martínez I, Piñón Sellés F. Arch Bronconeumol; 2007 Feb; 43(2):86-91. PubMed ID: 17288897 [Abstract] [Full Text] [Related]
15. Randomized clinical trial of the effect of microemulsion cyclosporin and tacrolimus on renal allograft fibrosis. Murphy GJ, Waller JR, Sandford RS, Furness PN, Nicholson ML. Br J Surg; 2003 Jun; 90(6):680-6. PubMed ID: 12808614 [Abstract] [Full Text] [Related]
16. Posttransplant diabetes mellitus in pediatric thoracic organ recipients receiving tacrolimus-based immunosuppression. Paolillo JA, Boyle GJ, Law YM, Miller SA, Lawrence K, Wagner K, Pigula FA, Griffith BP, Webber SA. Transplantation; 2001 Jan 27; 71(2):252-6. PubMed ID: 11213069 [Abstract] [Full Text] [Related]
17. Airway anastomosis complications in de novo lung transplantation with sirolimus-based immunosuppression. Groetzner J, Kur F, Spelsberg F, Behr J, Frey L, Bittmann I, Vogeser M, Ueberfuhr P, Meiser B, Hatz R, Reichart B, Munich Lung Transplant Group. J Heart Lung Transplant; 2004 May 27; 23(5):632-8. PubMed ID: 15135383 [Abstract] [Full Text] [Related]